Finance

Lists
FME:ETR
Fresenius Medical Care AG
40,25 €
+1,77%
(+0,70) 1D
5 հոկ, 17:35:03 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for FME...
Open
40,18 €
High
40,32 €
Low
39,71 €
Mkt. cap
10,79 մլրդ
Avg. vol.
798,00 հզր
Volume
565,54 հզր
Dividend
3,70%
Quarterly dividend
0,37 €
Ex-dividend date
22 մյս, 2026 թ.
P/E ratio
12,10
52-wk high
47,86 €
52-wk low
34,57 €
EPS
3,33 €
Shares outstanding
268,56 մլն
No. of employees
107 հզր
Open
40,18 €
High
40,32 €
Low
39,71 €
Mkt. cap
10,79 մլրդ
Avg. vol.
798,00 հզր
Volume
565,54 հզր
Dividend
3,70%
Quarterly dividend
0,37 €
Ex-dividend date
22 մյս, 2026 թ.
P/E ratio
12,10
52-wk high
47,86 €
52-wk low
34,57 €
EPS
3,33 €
Shares outstanding
268,56 մլն
No. of employees
107 հզր
News stories
From web sources and news partners
Profile
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease, which requires patients to undergo dialysis 3 times per week for the rest of their lives. With a global headquarters in Bad Homburg vor der Höhe, Germany, and a North American headquarters in Waltham, Massachusetts, it has a 38% market share of the dialysis market in the United States. It also operates 42 production sites, the largest of which are in the U.S., Germany, and Japan. The company is 32% owned by Fresenius and, as of 2020, generates around 50% of the group's revenue. As of 2024, the company was ranked as #612 on the World's Best Employers list published by Forbes. Wikipedia
About Fresenius Medical Care AG
CEOHelen Giza
Employees107 հզր
Founded1996
Headquarters-
SectorHealth care provider
Last report
04 օգս, 2026 թ.
Fiscal period
Q2 2026
EPS / Est. (EUR)
0,56 € / 0,50 €
+13,11%beat
Revenue / Est. (EUR)
4,86 մլրդ / 4,79 մլրդ
+1,47%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
4,88 մլրդ
5,07 մլրդ
4,61 մլրդ
4,86 մլրդ
Cost of goods sold
3,64 մլրդ
3,68 մլրդ
3,43 մլրդ
3,55 մլրդ
Cost of revenue
3,64 մլրդ
3,68 մլրդ
3,43 մլրդ
3,55 մլրդ
Research and development expenses
37,75 մլն
38,63 մլն
38,31 մլն
39,63 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
705,44 մլն
784,62 մլն
748,94 մլն
736,01 մլն
Operating expense
740,50 մլն
796,34 մլն
803,94 մլն
786,35 մլն
Total operating expenses
4,38 մլրդ
4,48 մլրդ
4,24 մլրդ
4,34 մլրդ
Operating income
501,72 մլն
592,03 մլն
375,56 մլն
523,63 մլն
Other non operating income
-
-
-
-
EBT including unusual items
402,57 մլն
508,46 մլն
207,52 մլն
383,00 մլն
EBT excluding unusual items
462,70 մլն
541,79 մլն
334,44 մլն
399,22 մլն
Income tax expense
75,22 մլն
106,44 մլն
42,75 մլն
89,83 մլն
Effective tax rate
18,69%
20,93%
20,60%
23,45%
Other operating expenses
-2,69 մլն
-26,91 մլն
16,69 մլն
10,71 մլն
Net income
274,80 մլն
327,08 մլն
117,53 մլն
218,38 մլն
Net profit margin
5,63%
6,45%
2,55%
4,49%
Earnings per share
1,10
1,44
0,91
0,56
Interest and investment income
19,16 մլն
13,62 մլն
14,62 մլն
14,70 մլն
Interest expense
-93,10 մլն
-99,02 մլն
-93,30 մլն
-97,55 մլն
Net interest expenses
-73,94 մլն
-85,40 մլն
-78,68 մլն
-82,86 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
853,56 մլն
780,17 մլն
727,79 մլն
879,38 մլն
Gain or loss from assets sale
50,35 մլն
17,92 մլն
8,77 մլն
-4,09 մլն
AI content may include mistakes. Learn more
Google Apps